≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Acute nephritic syndrome

DOID EFO Endpoint Browser PheWeb

N14_ACUTENEPHRITIC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N00#
  • Hospital discharge: ICD-9 — 580
  • Hospital discharge: ICD-8 — 580
  • Hospital discharge: excluded ICD-9 — 5804
  • Cause of death: ICD-10 — N00#
  • Cause of death: ICD-9 — 580
  • Cause of death: ICD-8 — 580
  • Cause of death: excluded ICD-9 — 5804

2 out of 7 registries used, show all original rules.

795

4. Check minimum number of events

None

795

5. Include endpoints

None

795

6. Filter based on genotype QC (FinnGen only)

795

Control definitions (FinnGen only)

Control exclude
N14_GLOMERULAR

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
N00-N08
Name in latin
Syndroma nephriticum acutum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6888 2571 4253
Only index persons 5423 2070 3353
Unadjusted period prevalence (%)
Whole population 0.10 0.07 0.12
Only index persons 0.11 0.08 0.13
Median age at first event (years)
Whole population 33.02 34.02 32.14
Only index persons 28.39 28.38 28.39

-FinnGen-

Key figures

All Female Male
Number of individuals 795 330 465
Unadjusted period prevalence (%) 0.17 0.11 0.20
Median age at first event (years) 31.34 28.60 33.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
732
Matched controls
7321
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
58099
ICD-8 Finland
Acute nephritis
+∞
323.0
343
*
N00.9
ICD-10 Finland
Acute nephritic syndrome, Unspecified
+∞
161.6
149
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
45.8
92.2
113
29
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
54.9
87.8
104
22
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
58.4
86.2
101
20
A11CC03
ATC
alfacalcidol; systemic
27.5
69.3
96
40
Z94.0
ICD-10 Finland
Kidney transplant status
69.4
65.8
75
12
A12AA04
ATC
calcium carbonate; oral
49.0
62.1
75
17
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
+∞
61.3
58
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
60.2
57
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
49.8
59.8
72
16
L04AA06
ATC
mycophenolic acid; systemic
25.9
59.1
83
36
N00.0
ICD-10 Finland
Acute nephritic syndrome, Minor glomerular abnormality
+∞
57.0
54
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
9.6
55.1
118
143
L04AD01
ATC
ciclosporin; systemic
22.5
54.0
79
39
R80
ICD-10 Finland
Isolated proteinuria
151.3
53.6
56
*
127
Kela drug reimbursment
Transplant complication
27.8
53.2
73
29
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
52.9
53.0
63
13
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
+∞
52.7
50
*
N18.8
ICD-10 Finland
Other chronic renal failure
17.2
51.6
83
54
TK800
NOMESCO Finland
Hemodialysis
19.4
50.1
77
44
N18.0
ICD-10 Finland
End-stage renal disease
41.4
49.0
61
16
B03XA02
ATC
darbepoetin alfa; parenteral
36.8
47.8
61
18
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
109.5
47.4
51
5
Z49.1
ICD-10 Finland
Extracorporeal dialysis
33.1
46.6
61
20
H02AB04
ATC
methylprednisolone; systemic
4.4
45.8
192
549
137
Kela drug reimbursment
Uraemia requiring dialysis
76.3
44.6
50
7
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
60.7
44.0
51
9
C03CA01
ATC
furosemide; systemic
3.3
43.1
291
1228
L04AA01
ATC
[U] ciclosporin; systemic
21.7
42.1
62
31
N00.2
ICD-10 Finland
Acute nephritic syndrome, Diffuse membranous glomerulonephritis
+∞
40.0
38
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
+∞
38.9
37
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
75.8
38.4
43
6
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
194.5
36.1
37
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
35.0
160
483
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
34.7
33
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
68.5
34.3
39
6
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
+∞
33.6
32
*
V03AE01
ATC
polystyrene sulfonate; oral
24.4
32.6
46
20
B03XA01
ATC
erythropoietin; parenteral
31.7
32.0
42
14
N04.2
ICD-10 Finland
Nephrotic syndrome, diffuse membranous glomerulonephritis
+∞
31.5
30
*
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
+∞
30.4
29
*
5809A
ICD-9 Finland
Acute glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA NUD,EI NEFR SDR]
+∞
30.4
29
*
B05DA
ATC
Isotonic solutions
111.4
29.9
32
*
N00.8
ICD-10 Finland
Acute nephritic syndrome, Other
+∞
28.3
27
*
Z49.2
ICD-10 Finland
Other dialysis
78.2
27.0
30
*
N00.3
ICD-10 Finland
Acute nephritic syndrome, Diffuse mesangial proliferative glomerulonephritis
+∞
26.2
25
*
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
+∞
26.2
25
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.0
26.0
56
67
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
28.2
26.0
35
13
L04AX01
ATC
azathioprine; systemic
5.7
26.0
78
151
B05DB
ATC
Hypertonic solutions
140.0
25.8
27
*
205
Kela drug reimbursment
Chronic hypertension
2.5
25.7
252
1254
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.7
24.9
90
214
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.0
24.9
71
129
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.6
24.4
64
104
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
69.9
24.0
27
*
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
+∞
23.0
22
*
58399
ICD-8 Finland
Nephritis, unqualified
+∞
23.0
22
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
53.8
22.2
26
5
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
22.0
21
*
58199
ICD-8 Finland
Nephrotic syndrome
+∞
22.0
21
*
N19
ICD-10 Finland
Unspecified kidney failure
7.3
20.6
50
73
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
20.5
77
190
196
Kela drug reimbursment
Paricalcitol and cinacalcet
49.5
20.3
24
5
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
19.9
19
*
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
19.9
19
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.4
19.3
73
181
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
19.2
241
1317
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
56.6
19.0
22
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.4
18.1
31
24
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
184.3
17.6
18
*
V03AE02
ATC
sevelamer; oral
64.9
16.8
19
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
64.9
16.8
19
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
64.9
16.8
19
*
58209
ICD-8 Finland
Chronic nephritis, Unspecified
+∞
16.7
16
*
7151
FHL
Kidney transplantation
+∞
16.7
16
*
N03.5
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis
+∞
16.7
16
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.0
16.2
67
181
C09AA02
ATC
enalapril; systemic
2.3
16.1
167
824
L01AA01
ATC
cyclophosphamide; systemic
25.1
16.1
22
9
C08CA01
ATC
amlodipine; oral
2.0
15.8
267
1631
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
15.7
15
*
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
+∞
15.7
15
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
15.7
15
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.4
15.7
41
67
C02AC05
ATC
moxonidine; oral
4.7
15.6
54
123
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
15.5
97
359
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
7.4
15.2
36
51
78930
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Haematuria
32.4
14.9
19
6
N00.5
ICD-10 Finland
Acute nephritic syndrome, Diffuse mesangiocapillary glomerulonephritis
+∞
14.6
14
*
5809B
ICD-9 Finland
Acute glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA NUD,NEFR SDR]
+∞
14.6
14
*
C08CA02
ATC
felodipine; oral
2.9
13.9
87
320
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
54.4
13.9
16
*
V03AE03
ATC
lanthanum carbonate; oral
76.6
13.6
15
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
13.6
13
*
N00.7
ICD-10 Finland
Acute nephritic syndrome, Diffuse crescentic glomerulonephritis
+∞
13.6
13
*
N00.1
ICD-10 Finland
Acute nephritic syndrome, Focal and segmental glomerular lesions
+∞
13.6
13
*
H02AB06
ATC
prednisolone; systemic
1.8
13.5
335
2313
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
142.5
13.5
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
13.4
317
2150
H05BX01
ATC
cinacalcet; oral
18.6
13.4
20
11
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
40.9
13.2
16
*
M04AA01
ATC
allopurinol; systemic
2.5
13.2
112
496
C08CA13
ATC
lercanidipine; oral
2.5
13.0
106
459
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
50.9
12.9
15
*
C10AA05
ATC
atorvastatin; oral
1.8
12.4
267
1745
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
38.2
12.2
15
*
TK810
NOMESCO Finland
Hemofiltration
16.7
11.7
18
11
321
Kela drug reimbursment
Paricalcitol and cinacalcet
16.7
11.7
18
11
L01BB01
ATC
NA
66.0
11.6
13
*
5808A
ICD-9 Finland
Acute glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA ALIA,EI NEFR SDR]
+∞
11.5
11
*
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
11.5
11
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
121.8
11.5
12
*
I15.0
ICD-10 Finland
Renovascular hypertension
20.4
11.2
16
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
11.0
126
642
N04.3
ICD-10 Finland
Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
10.4
10
*
5819X
ICD-9 Finland
Nephrotic syndrome with unspecified pathological lesion in kidney
+∞
10.4
10
*
5813A
ICD-9 Finland
Nephrotic syndrome, With lesion of minimal change glomerulonephritis
+∞
10.4
10
*
R50.9
ICD-10 Finland
Fever, unspecified
2.2
10.4
111
546
R31
ICD-10 Finland
Unspecified haematuria
2.4
10.0
88
397
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.0
10.0
31
64
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
40.6
10.0
12
*
TK820
NOMESCO Finland
Peritoneal dialysis
40.6
10.0
12
*
ZX120
NOMESCO Finland
Intravenous
2.4
9.8
83
364
WW200
NOMESCO Finland
Immunization
4.3
9.7
35
85
3AC01
NOMESCO Finland
NA
8.0
9.7
21
27
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
9.6
88
405
C08CA05
ATC
nifedipine; systemic
2.8
9.5
60
225
Z99.2
ICD-10 Finland
Dependence on renal dialysis
101.3
9.4
10
*
M31.3
ICD-10 Finland
Wegener granulomatosis
30.4
9.4
12
*
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
9.4
9
*
D638, N188
ICD-10 Finland
NA
+∞
9.4
9
*
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
+∞
9.4
9
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
15.8
9.1
14
9
C07AB02
ATC
metoprolol; systemic
1.9
8.8
144
843
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.2
8.7
45
148
H02AB09
ATC
hydrocortisone; systemic
4.7
8.7
28
61
M05BA04
ATC
alendronic acid; oral
2.7
8.6
58
225
C09CA07
ATC
telmisartan; oral
2.6
8.6
61
243
C09CA01
ATC
losartan; oral
1.8
8.6
168
1042
XPX08
NOMESCO Finland
Intraoperative flow measurement
9.1
8.6
17
19
A46
ICD-10 Finland
Erysipelas
2.1
8.6
105
551
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
91.1
8.4
9
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
8.3
8
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
8.3
74
337
A02BC01
ATC
omeprazole; systemic
1.7
8.2
193
1267
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
8.2
92
464
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.1
8.2
21
35
M10.9
ICD-10 Finland
Gout, unspecified
2.7
8.1
55
214
N25.0
ICD-10 Finland
Renal osteodystrophy
33.7
8.1
10
*
UJF32
NOMESCO Finland
Coloscopy
1.7
8.1
174
1110
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.4
8.0
18
25
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
8.0
494
5655
C09CA06
ATC
candesartan; oral
1.8
8.0
146
886
C10AA04
ATC
fluvastatin; oral
2.4
7.9
66
290
U14
ICPC
Kidney symptom/complaint
7.1
7.8
18
26
ZXD05
NOMESCO Finland
Urgent procedure
1.6
7.8
219
1507
RD210
NOMESCO Finland
NA
5.4
7.7
22
42
C02CA01
ATC
prazosin; oral
5.7
7.7
21
38
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
7.7
70
320
M10.3
ICD-10 Finland
Gout due to impairment of renal function
18.6
7.6
11
6
RS220
NOMESCO Finland
NA
7.2
7.5
17
24
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
80.9
7.4
8
*
J01MA14
ATC
moxifloxacin; systemic
2.3
7.3
70
328
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
7.3
114
653
U88
ICPC
Glomerulonephritis/nephrosis
+∞
7.3
7
*
N04.4
ICD-10 Finland
Nephrotic syndrome, diffuse endocapillary proliferative glomerulonephritis
+∞
7.3
7
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
7.3
7
*
B01AB10
ATC
tinzaparin; parenteral
2.6
7.3
53
216
B01AC04
ATC
clopidogrel; oral
1.9
7.3
108
608
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
30.3
7.2
9
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
7.1
34
107
5997A
ICD-9 Finland
Other disorders of urethra and urinary tract, Haematuria
12.2
7.1
12
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.1
161
1039
J01MA12
ATC
levofloxacin; systemic
1.8
7.0
133
813
A02BC02
ATC
pantoprazole; systemic
1.5
6.9
430
3551
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
11.1
6.8
12
11
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.6
6.8
29
84
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
40.4
6.8
8
*
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
22.7
6.7
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
6.6
25
65
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
12.4
6.6
11
9
C07AG02
ATC
carvedilol; oral
2.6
6.6
46
184
ZX108
NOMESCO Finland
Inhalation
8.8
6.6
13
15
R60.1
ICD-10 Finland
Generalized oedema
10.1
6.5
12
12
ZXA00
NOMESCO Finland
Right side
1.6
6.5
171
1148
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
6.5
42
162
Z2446
NOMESCO Finland
Social worker
2.4
6.5
52
226
A12BA01
ATC
potassium chloride; oral
3.0
6.3
33
112
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.1
6.3
70
353
N04.5
ICD-10 Finland
Nephrotic syndrome, diffuse mesangiocapillary glomerulonephritis
+∞
6.3
6
*
N03.7
ICD-10 Finland
Chronic nephritic syndrome, diffuse crescentic glomerulonephritis
+∞
6.3
6
*
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
+∞
6.3
6
*
N04.89
ICD-10 Finland
Nephrotic syndrome, other
+∞
6.3
6
*
N00
ICD-10 Finland
Acute nephritic syndrome
+∞
6.3
6
*
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
6.3
6
*
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
26.9
6.2
8
*
K65.0
ICD-10 Finland
Acute peritonitis
5.8
6.2
16
28
S97
ICPC
Chronic ulcer skin
2.7
6.2
40
154
C09AA05
ATC
ramipril; oral
1.6
6.1
165
1114
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
6.1
65
323
J01DB01
ATC
cefalexin; oral
1.5
6.0
555
4911
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.2
6.0
29
93
C10AA01
ATC
simvastatin; oral
1.5
6.0
276
2112

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
243
543
6.00
108.90
20.8
7.1
mmol/l
12.3
9.2
7.48
236
517
(40768446) Kidney Pathology biopsy report
60
10
64.82
108.28
2.0
1.7
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
73
28
28.61
106.96
25.9
35.8
ug/l
81.0
142.3
4.31
65
23
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
197
429
5.78
89.50
11.8
3.8
ng/l
129.9
76.7
7.42
185
379
(3003458) Phosphate [Moles/volume] in Serum or Plasma
273
809
4.62
85.43
21.6
5.5
mmol/l
1.1
1.0
5.93
268
753
(3026250) Tacrolimus [Mass/volume] in Blood
51
25
21.73
67.61
31.7
24.5
ug/l
6.9
7.6
0.61
43
20
(3017817) Protein [Mass] in Urine collected for unspecified duration
53
46
12.27
52.08
4.6
2.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
111
263
4.74
44.20
2.9
1.4
u/ml
12.9
7.1
—
10
8
(3042733) HLA Ab [Presence] in Serum
34
18
19.69
43.33
6.1
4.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
69
121
6.15
38.31
10.0
6.2
iu/ml
393.5
392.6
0.00
13
21
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
205
815
3.04
37.64
7.3
2.4
%
24.0
23.5
0.20
182
703
(3000850) Epithelial cells [#/volume] in Urine
272
1281
2.71
36.14
6.0
2.4
e6/l
3.1
5.3
2.28
251
1130
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
58
97
6.37
33.71
7.6
2.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
97
260
4.11
32.66
2.5
1.9
g/l
1.5
1.5
0.38
89
228
(3012516) Albumin [Mass/volume] in Urine
335
1824
2.45
32.05
8.8
3.1
mg/l
215.1
172.3
0.25
295
1203
(3020682) Albumin/Creatinine [Ratio] in Urine
347
1926
2.42
31.73
10.1
3.8
mg/mmol
39.3
6.1
7.61
302
1246
(3009508) Creatinine [Moles/volume] in Urine
352
1968
2.42
31.64
9.8
3.0
mmol/l
7.0
8.1
5.65
330
1652
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
104
303
3.80
31.11
13.0
4.4
mmol/l
23.4
24.2
1.57
94
272
(3018418) pH of Serum or Plasma
323
1760
2.41
30.52
15.3
3.9
ph
7.4
7.4
0.63
60
336
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
41
52
8.26
30.49
1.6
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
5
70.83
30.12
5.0
7.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
154
591
2.99
29.52
13.1
3.9
mmol/l
1.1
2.0
2.07
126
475
(21494890) Protein electrophoresis panel - 24 hour Urine
40
52
8.05
29.14
2.5
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
377
2237
2.30
28.80
9.7
3.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
458
2990
2.25
27.25
22.1
6.8
mmol/l
1.2
1.2
0.07
406
2535
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
26
20
13.41
27.24
3.1
3.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
82
226
3.93
26.44
9.7
3.6
g/l
0.9
0.2
2.21
58
97
(3002582) Erythrocytes [#/volume] in Urine
325
1879
2.23
25.69
8.5
3.1
e6/l
22.6
99.5
1.50
287
1451
(3020630) Protein [Mass/volume] in Serum or Plasma
129
485
2.98
25.44
3.1
2.8
g/l
63.2
66.8
4.42
121
441
(3004588) Protein electrophoresis panel - Serum or Plasma
111
388
3.16
24.81
2.4
2.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
408
2611
2.16
24.65
15.0
4.9
g/l
34.4
35.7
4.96
399
2442
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
76
209
3.92
24.55
2.1
1.5
titre
266.7
173.3
—
6
6
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
384
2406
2.15
24.44
3.8
2.2
nmol/l
75.9
76.2
0.08
368
2149
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
74
202
3.94
24.15
2.3
1.4
g/l
1.1
1.2
1.47
69
192
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
72
194
3.98
23.92
2.3
1.4
g/l
0.3
0.2
0.60
65
184
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
417
2712
2.13
23.91
18.3
6.3
mmol/l
1.2
1.2
0.55
401
2468
(3026782) Osmolality of Urine
232
1197
2.32
23.79
6.5
2.7
mosm/kgh2o
481.1
573.1
11.66
209
1026
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
186
4.03
23.71
4.1
3.4
u/ml
0.3
0.4
1.38
39
106
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
60
142
4.49
23.64
2.6
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
57
131
4.61
23.29
3.0
1.4
u/ml
132.3
107.3
—
9
25
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
61
149
4.35
23.09
1.7
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
293
1681
2.18
23.07
5.3
2.7
umol/l
386.3
7063.3
6.24
276
1469
(3030467) Casts [#/volume] in Urine by Automated count
296
1714
2.16
22.69
8.0
3.0
e6/l
0.2
0.4
1.98
259
1292
(36304419) Bacteria [Presence] in Urine
288
1659
2.15
22.29
7.6
3.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
129
520
2.77
22.22
15.7
9.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
159
718
2.52
21.75
3.3
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
58
143
4.30
21.68
1.9
1.3
u/ml
281.5
264.6
0.14
41
84
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
203
1056
2.24
19.97
5.9
2.7
e6/l
0.5
1.0
3.72
150
621
(3011397) Hemoglobin [Presence] in Urine by Test strip
246
1384
2.13
19.84
6.6
3.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
37
68
5.66
19.47
1.1
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
343
2190
2.00
19.46
10.1
3.6
e6/l
44.5
92.9
1.17
293
1561
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
120
504
2.63
18.93
4.1
2.9
ml/min/173m2
41.5
67.8
10.22
58
201
(3027945) Reticulocytes/100 erythrocytes in Blood
148
689
2.41
18.76
4.4
2.8
%
1.8
1.8
0.17
143
623
(42870588) Differential panel, method unspecified - Blood
325
2072
1.96
18.21
8.5
6.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
191
1004
2.19
18.12
5.8
3.7
mmol/l
0.8
0.8
2.09
185
951
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
73
5.27
18.04
2.2
2.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
44
103
4.46
17.55
2.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
431
3052
1.90
17.29
9.4
4.5
estimate
0.0
0.0
0.50
83
584
(3018677) aPTT in Platelet poor plasma by Coagulation assay
183
969
2.15
16.92
3.2
2.5
s
29.5
29.8
0.36
176
942
(3009261) Glucose [Presence] in Urine by Test strip
432
3090
1.87
16.51
7.0
3.4
estimate
0.0
0.0
0.50
82
559
(40760888) Immunoglobulin light chains.free panel - Serum
48
127
3.96
16.32
3.1
4.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
427
3051
1.86
16.29
7.0
3.3
estimate
0.0
0.0
0.00
78
575
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
21
7
30.76
16.17
10.8
13.9
mmol/l
4.8
6.9
—
21
7
(3023520) Reticulocytes [#/volume] in Blood
115
509
2.47
16.16
4.8
2.8
e9/l
71.2
69.9
0.14
78
402
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
58
178
3.44
15.89
3.4
4.2
mg/l
42.5
32.3
0.70
43
146
(3034860) Kappa light chains.free [Mass/volume] in Serum
58
178
3.44
15.89
3.4
4.2
mg/l
64.6
87.5
0.27
43
143
(3048929) Epstein Barr virus Ab [Presence] in Serum
67
226
3.15
15.76
1.7
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
52
5.75
15.65
1.5
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
17
16
10.84
15.58
1.0
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
170
911
2.10
15.08
2.9
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
20
25
8.18
14.94
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
20
25
8.18
14.94
1.1
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
440
3229
1.81
14.86
9.4
6.3
e9/l
0.2
0.2
0.03
402
2878
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
180
996
2.04
14.61
6.8
2.9
e6/l
1.3
1.8
0.58
127
564
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
138
690
2.21
14.58
3.5
4.6
u/l
226.9
256.1
1.43
132
657
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
166
894
2.08
14.48
3.3
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
428
3136
1.79
14.33
9.4
5.9
e9/l
0.0
0.0
0.03
391
2739
(3023368) Bacteria identified in Blood by Culture
268
1715
1.85
14.03
7.5
4.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
425
3120
1.78
14.02
9.4
5.9
e9/l
0.6
0.6
1.32
390
2715
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
19
9.12
13.81
1.0
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
434
3215
1.77
13.79
9.6
6.0
e9/l
1.8
1.9
1.46
396
2862
(3024928) Oxygen saturation in Venous blood
45
134
3.50
12.92
6.2
4.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
107
506
2.29
12.86
7.7
3.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
187
1096
1.92
12.69
3.3
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
135
712
2.08
12.32
2.2
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
470
3628
1.72
12.31
12.8
9.4
e9/l
4.4
4.1
1.93
431
3192
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
396
2.37
11.83
9.1
3.6
mmol/l
1.2
1.8
0.84
67
290
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
132
706
2.04
11.56
2.2
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
101
489
2.22
11.44
4.1
2.7
g/l
9.3
10.8
2.21
94
447
(3006504) Eosinophils/100 leukocytes in Blood
392
2933
1.66
11.09
10.0
6.1
%
2.8
2.9
0.54
383
2751
(3037756) Immunofixation for Serum or Plasma
40
122
3.40
11.08
1.5
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
30
75
4.12
11.03
1.3
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
394
2955
1.66
11.02
10.2
6.4
%
8.6
8.7
0.11
385
2789
(1616796) Gas panel - Central venous blood
41
128
3.32
10.96
7.0
3.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
29
71
4.20
10.95
1.4
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
51
184
2.89
10.69
1.6
1.5
iu/ml
0.0
0.0
—
5
35
(3009343) pH of Capillary blood
89
421
2.25
10.65
9.2
3.5
ph
7.4
7.4
0.04
19
52
(3022096) Basophils/100 leukocytes in Blood
380
2845
1.64
10.55
10.0
6.2
%
0.7
0.7
0.00
373
2676
(3018010) Neutrophils/100 leukocytes in Blood
395
2991
1.64
10.44
9.9
6.0
%
59.1
57.2
2.44
388
2831
(3002030) Lymphocytes/100 leukocytes in Blood
399
3042
1.63
10.16
9.8
6.2
%
26.3
27.9
2.14
389
2859
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
120
651
1.99
10.04
5.3
3.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
48
174
2.87
9.98
4.5
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
47
169
2.89
9.92
2.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
130
734
1.92
9.67
2.4
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
166
1017
1.80
9.53
2.4
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
203
2.67
9.42
2.3
2.7
g/l
9.2
10.7
1.59
45
175
(3037522) Nuclear Ab [Titer] in Serum
140
817
1.87
9.40
1.4
1.3
titre
487.1
462.6
0.05
28
163
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
210
2.63
9.32
2.2
2.7
g/l
3.1
3.1
0.16
44
167
(3031040) Bacteria [#/volume] in Urine by Automated count
495
4027
1.61
9.27
6.9
4.1
e6/l
93.1
1781.9
—
8
59
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
193
2.70
9.26
2.5
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
153
2.91
9.26
1.5
1.6
—
—
—
0
0
(3025315) Body weight
12
5
24.32
8.93
5.7
3.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
113
625
1.94
8.91
6.6
9.3
%
95.2
95.5
0.21
106
602
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
221
2.55
8.91
2.2
2.6
g/l
3.7
3.8
0.35
42
165
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
221
2.55
8.91
2.2
2.6
g/l
7.5
7.2
0.63
43
173
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
221
2.55
8.91
2.2
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
353
2673
1.58
8.85
6.0
2.7
ug/l
197.4
141.5
3.52
336
2475
(3011648) Oxygen content in Venous blood
23
56
4.20
8.76
5.2
4.7
%
10.7
10.4
0.13
23
56
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
87
444
2.08
8.58
2.1
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
43
162
2.75
8.35
8.2
3.1
kpa
9.2
8.4
1.71
43
144
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
46
180
2.65
8.31
2.3
1.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
48
192
2.60
8.30
2.5
2.9
g/l
0.5
1.1
0.81
39
170
(3021879) Hepatitis B virus core Ab [Presence] in Serum
86
447
2.04
8.08
2.3
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
36
126
2.95
8.00
4.5
2.6
%
16.5
16.1
0.24
25
67
(3026008) Bacteria identified in Urine by Culture
240
1699
1.59
7.82
3.9
2.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
76
383
2.09
7.75
6.7
7.9
mmol/l
23.9
24.6
0.53
70
354
(3037467) Urinalysis macro (dipstick) panel - Urine
511
4279
1.54
7.69
10.1
4.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
125
2.88
7.52
3.6
2.3
g/l
128.8
131.6
0.27
30
95
(40758558) Short blood count panel - Blood
221
1549
1.59
7.46
9.7
7.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
101
572
1.88
7.39
6.6
9.9
g/l
116.6
122.2
1.68
95
549
(3003396) Base excess in Arterial blood by calculation
117
694
1.80
7.38
6.7
8.8
mmol/l
0.9
1.2
0.19
84
542
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
23
64
3.67
7.34
1.4
1.2
titre
170.0
212.0
—
5
10
(3015235) Bicarbonate [Moles/volume] in Capillary blood
42
168
2.58
7.29
5.5
2.6
mmol/l
23.4
24.6
0.95
42
144
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
559
4805
1.55
7.21
13.4
7.7
u/l
77.8
78.4
0.09
540
4509
(3032080) INR in Blood by Coagulation assay
328
2527
1.51
7.15
11.6
8.9
inr
1.2
1.2
0.30
89
751
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
10
5
20.23
7.14
1.1
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
13
7.78
7.13
2.8
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
100
581
1.82
6.74
2.5
2.2
nmol/l
337.6
374.5
0.96
92
540
(3012501) Base excess in Blood by calculation
35
133
2.71
6.72
7.3
3.4
mmol/l
2.5
2.4
0.11
22
83
(3028026) IgM [Mass/volume] in Serum or Plasma
75
398
1.98
6.65
2.2
1.6
g/l
1.1
1.5
1.10
68
366
(3021901) Oxygen saturation in Capillary blood
32
117
2.81
6.61
5.2
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
55
262
2.18
6.49
2.5
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
149
2.56
6.36
1.5
1.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
0
+∞
6.26
3.5
0.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
0
+∞
6.26
3.5
0.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
253
1889
1.50
6.24
2.3
2.1
u/l
215.4
298.4
0.47
241
1782
(3022313) Gas panel - Capillary blood
62
315
2.05
6.21
11.1
3.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
225
1643
1.52
6.16
7.9
3.6
estimate
0.0
0.0
0.80
75
571
(3044927) Protein electrophoresis panel - Urine
21
63
3.40
6.03
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
211
1526
1.52
6.03
2.8
2.2
mg/l
3.1
3.1
0.02
187
1300
(3047189) Immunofixation for 24 hour Urine
14
31
4.58
6.00
1.8
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
95
2.91
5.99
2.0
1.5
g/l
0.8
0.7
0.16
20
71
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
148
2.50
5.94
1.5
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
217
1583
1.51
5.94
6.2
4.2
%
96.6
89.4
3.58
210
1550
(3021589) Normoblasts [#/volume] in Blood
350
2807
1.44
5.89
17.4
9.6
e9/l
0.0
0.0
0.35
301
2323
(3035880) pH of Pleural fluid
14
32
4.44
5.78
1.6
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
72
396
1.90
5.77
4.9
5.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
23
76
3.09
5.68
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
41
183
2.31
5.67
1.5
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
257
1956
1.46
5.65
3.2
2.6
u/l
60.9
56.6
0.51
236
1814
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
104
2.75
5.65
1.8
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
29
110
2.70
5.62
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
200
1449
1.51
5.62
1.7
1.5
nmol/l
19.3
20.2
0.39
188
1237
(3051651) Icteric interference index of Serum or Plasma
16
42
3.87
5.56
6.3
4.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
88
2.90
5.55
1.6
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
30
117
2.63
5.52
2.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
117
2.63
5.52
2.2
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
82
477
1.80
5.51
12.9
3.3
mmol/l
1.2
1.2
0.55
74
419
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
50
246
2.10
5.47
2.7
1.8
ug/l
5.9
2.5
0.63
45
220
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
112
2.65
5.44
1.4
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
96
587
1.72
5.44
2.3
2.7
g/l
0.2
0.2
1.24
91
548
(3015377) Calcium [Moles/volume] in Serum or Plasma
261
2013
1.44
5.29
5.9
3.3
mmol/l
2.3
2.3
1.29
248
1756
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
22
5.06
5.27
1.5
1.0
miu/ml
1125.7
1515.6
0.58
11
22
(3017181) Myelocytes/100 leukocytes in Blood
88
530
1.74
5.26
5.3
4.6
%
1.1
1.0
0.20
34
160
(3045788) Cell count panel - Pleural fluid
17
49
3.52
5.19
1.6
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
14
35
4.05
5.18
4.6
1.9
min
524.5
479.0
1.03
14
24
(3002179) Metamyelocytes/100 leukocytes in Blood
81
481
1.76
5.09
4.8
4.4
%
0.6
0.5
0.22
27
120
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
55
3.33
5.05
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
27
105
2.63
5.01
1.5
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
363
1.86
4.99
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
66
3.08
4.97
1.5
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
389
3244
1.39
4.96
6.6
6.7
umol/l
10.1
11.7
2.42
370
3080
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
44
216
2.10
4.87
3.2
2.9
—
—
—
0
0
(3017704) Immunofixation for Urine
14
37
3.83
4.83
1.2
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
280
1.96
4.81
1.8
2.1
u/l
38.3
38.5
0.02
43
256
(3021440) Promyelocytes/100 leukocytes in Blood
82
497
1.72
4.80
5.2
4.8
%
0.1
0.2
0.09
35
144
(3051611) Lipemic interference index of Serum or Plasma
18
58
3.15
4.66
5.7
4.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
78
471
1.73
4.63
5.4
4.7
%
0.0
0.2
0.87
29
125
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
5
14.11
4.58
1.4
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
437
3744
1.37
4.57
8.1
5.0
mmol/l
6.8
6.7
0.67
421
3501
(3019150) Specific gravity of Urine by Refractometry
182
1350
1.45
4.44
7.3
3.6
kg/l
1.0
1.0
0.11
24
176
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
19
66
2.92
4.35
1.1
1.1
u/l
56.9
66.4
0.27
13
46
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
83
2.70
4.35
1.5
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
171
2.16
4.35
3.9
2.2
ug/min
250.0
65.2
1.21
25
101
(3019309) Folate [Moles/volume] in Red Blood Cells
152
1104
1.47
4.12
1.9
1.7
nmol/l
1422.7
1179.5
1.89
130
839
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
93
2.52
3.99
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
292
2392
1.35
3.89
7.6
3.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
31
146
2.17
3.85
1.3
1.2
u/ml
3.0
12.2
—
5
26
(3020891) Body temperature
46
252
1.88
3.79
8.0
4.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
96
2.44
3.75
1.6
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
63
383
1.70
3.69
2.0
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
16
5.68
3.66
1.0
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
30
3.70
3.65
1.0
1.5
nmol/l
134.5
139.3
0.14
11
30
(4035726)
80
522
1.59
3.56
1.5
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
345
2932
1.31
3.46
5.7
4.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
160
2.04
3.44
1.8
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
58
2.79
3.43
1.5
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
58
2.79
3.43
1.8
1.3
e6/l
2669.5
33203.0
—
10
31
(3000494) Fungus identified in Specimen by Culture
108
761
1.49
3.40
1.7
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
43
3.06
3.26
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
86
2.36
3.10
1.6
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
511
4617
1.30
3.09
6.3
4.0
mm/h
19.1
11.2
13.12
491
4268
(3010144) Erythrocytes [#/volume] in Synovial fluid
15
56
2.71
3.07
1.5
1.3
e6/l
443534.0
188819.6
—
10
43
(21494815) CD4 cells/100 lymphocytes in Specimen
15
56
2.71
3.07
2.6
2.2
—
39.4
—
0
7
(1761868) Lipid panel - Serum or Plasma
194
2395
0.75
3.06
3.2
2.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
62
2.61
3.06
1.4
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
105
753
1.45
3.04
13.8
7.0
—
—
—
0
0
(4062490)
14
51
2.78
3.00
1.2
1.2
—
—
—
0
0
(44790048)
18
76
2.40
2.91
1.4
1.5
—
—
—
0
0
(44790049)
18
76
2.40
2.91
1.4
1.5
—
—
—
0
0
(44806118)
18
76
2.40
2.91
1.4
1.5
—
—
—
0
0
(44790047)
18
76
2.40
2.91
1.4
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
55
345
1.64
2.91
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
221
1808
1.31
2.83
3.5
3.1
ng/l
6203.4
1236.9
3.04
198
1547
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
47
2.80
2.82
1.7
1.4
%
33.7
25.0
0.44
13
34
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
36
3.08
2.81
1.6
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
290
2462
1.28
2.79
2.0
2.0
pmol/l
96.4
94.5
0.27
156
1332
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
6
8.38
2.75
1.2
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
6
8.38
2.75
2.6
1.2
ng/l
99.2
77.2
—
5
6
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
10
6.04
2.70
3.5
2.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
321
1.63
2.68
9.1
13.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
114
2.05
2.58
1.8
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
16
68
2.38
2.57
2.9
2.2
pg
34.2
33.5
0.36
16
68
(40760892) CBC W Ordered Manual Differential panel - Blood
179
1441
1.31
2.55
6.4
4.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
7
7.18
2.55
3.4
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
7
7.18
2.55
3.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
7
7.18
2.55
3.4
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
11
5.49
2.54
1.7
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
13
50
2.63
2.54
1.2
1.2
g/l
5.8
7.2
—
8
34
(3028192) IgG subclass 2 [Mass/volume] in Serum
13
50
2.63
2.54
1.2
1.2
g/l
2.4
2.9
—
8
34
(3024139) IgG subclass 3 [Mass/volume] in Serum
13
50
2.63
2.54
1.2
1.2
g/l
0.3
0.4
—
8
32
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
122
2.00
2.52
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
122
2.00
2.52
1.5
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
34
195
1.78
2.50
4.6
8.2
mmol/l
1.2
1.2
0.36
27
171
(3003181) Sodium [Moles/volume] in Urine
20
95
2.13
2.50
1.5
1.3
mmol/l
52.3
60.0
0.46
15
85
(21494814) CD8 cells/100 lymphocytes in Specimen
7
16
4.40
2.48
1.3
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
25
131
1.94
2.43
3.6
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
177
0.33
2.42
1.0
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
43
267
1.65
2.40
3.1
2.8
—
—
—
0
0
(3004451) EKG impression Narrative
9
27
3.36
2.39
1.6
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
58
2.44
2.38
2.6
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
8
6.28
2.37
2.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
21
105
2.03
2.32
1.4
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
23
119
1.96
2.32
1.4
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
282
2429
1.25
2.32
4.6
3.6
ng/l
74.9
39.4
0.55
207
1687
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
59
2.40
2.30
5.3
2.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
18
85
2.14
2.30
1.4
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
158
1272
1.30
2.25
1.6
1.7
pmol/l
464.5
21428995.5
0.97
139
1064
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
670
6372
1.33
2.23
30.2
13.9
mg/l
23.0
24.4
0.58
573
5026
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
9
5.58
2.21
1.4
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
100
754
1.37
2.21
2.7
3.2
umol/l
11.0
8.3
0.47
85
659
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
32
188
1.73
2.20
5.6
3.4
%
188.2
189.6
0.03
32
181
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
122
1.91
2.18
4.8
3.5
e9/l
3.7
4.3
0.65
23
122
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
14
61
2.32
2.15
1.1
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
25
3.22
2.10
11.0
2.8
%
129.6
129.3
—
8
25
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
124
1.88
2.09
5.5
4.0
%
53.2
58.0
1.00
23
124
(3052592) Norovirus Ag [Presence] in Stool
5
10
5.02
2.07
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
75
545
1.42
2.07
2.7
2.4
ug/l
3.9
7.7
4.33
67
490
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
182
1510
1.27
2.04
3.5
2.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
11
4.57
1.94
3.4
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
232
1991
1.23
1.92
3.7
2.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
13
58
2.26
1.91
7.5
3.0
mg/l
64.0
35.0
0.47
13
44
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
126
1007
1.30
1.90
1.2
1.3
iu/ml
28.3
34.1
0.39
41
306
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
136
1.79
1.89
2.1
1.4
—
—
—
0
0
(3036489) Thrombin time
38
245
1.58
1.87
4.2
2.8
s
21.4
21.5
0.05
33
223
(3001019) Free T4 and TSH panel - Serum or Plasma
17
315
0.53
1.87
1.2
1.6
—
—
—
0
0
(4024509)
11
46
2.41
1.86
1.1
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
14
66
2.14
1.82
5.6
6.2
mmol/l
7.9
6.9
0.48
14
54
(4268621)
14
67
2.11
1.76
2.1
2.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
54
2.24
1.74
1.2
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
24
2.93
1.72
1.3
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
13
3.86
1.71
3.6
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
13
3.86
1.71
1.4
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
480
4455
1.20
1.69
4.5
3.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
55
2.20
1.68
1.7
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
55
2.20
1.68
1.7
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
55
2.20
1.68
1.7
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
19
3.17
1.66
2.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
1.8
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
173
1.64
1.66
1.4
1.5
ug/g
263.4
282.9
0.16
20
107
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
614
5841
1.22
1.62
7.3
5.7
mmol/mol
39.8
39.8
0.01
590
5448
(3011412) CD3 cells [#/volume] in Blood
12
56
2.16
1.61
1.5
2.2
e9/l
1.3
1.2
—
7
28
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
288
1.48
1.61
2.5
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
32
2.51
1.60
1.8
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
609
0.69
1.59
2.0
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
46
322
1.45
1.59
9.0
11.2
mmol/l
23.2
24.5
1.48
41
302
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
170
1.61
1.50
1.4
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
164
1392
1.22
1.49
2.3
1.8
mg/l
1.7
1.2
0.94
134
1060
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
37
2.45
1.48
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
192
1658
1.21
1.47
2.0
1.7
mmol/l
1.5
1.4
0.65
169
1404
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
38
2.38
1.46
2.4
2.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
80
1.89
1.45
2.1
4.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
188
1.56
1.44
1.1
1.4
miu/ml
149.3
250.4
—
10
88
(3002385) Erythrocyte distribution width [Ratio]
562
5325
1.19
1.43
33.9
16.9
%
13.9
13.6
5.23
555
5228
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
103
1.76
1.41
1.2
1.2
u/ml
1.7
2.3
—
6
36
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
103
1.76
1.41
1.1
1.2
u/ml
7.0
6.0
—
7
46
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
9
40
2.26
1.40
1.2
1.1
u/l
31.9
16.1
—
9
34
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
41
2.21
1.37
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
70
543
1.32
1.35
2.4
1.7
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
9
42
2.16
1.34
1.2
1.1
u/l
85.2
72.6
—
9
37
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
138
1618
0.82
1.30
2.5
2.9
ug/l
0.8
0.8
0.06
94
1038
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
34
2.37
1.29
1.1
1.2
ug/l
7.9
6.1
—
8
28
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
237
2112
1.17
1.27
3.8
3.5
u/l
29.7
33.7
1.64
230
2012
(3019550) Sodium [Moles/volume] in Serum or Plasma
674
6517
1.22
1.26
35.4
16.0
mmol/l
139.5
139.7
1.23
665
6341
(4306422)
16
92
1.75
1.25
1.3
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
25
2.41
1.24
3.3
3.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.0
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
36
2.23
1.24
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
36
2.23
1.24
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
36
2.23
1.24
1.8
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
53
400
1.35
1.24
3.8
2.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
63
1.92
1.23
2.5
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
675
6533
1.22
1.22
36.6
16.1
mmol/l
4.1
4.0
8.12
665
6352
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
19
2.64
1.21
4.0
3.1
u/l
250.2
209.7
—
5
19
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
19
2.64
1.21
1.0
1.1
%
132.8
127.3
—
5
19
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
491
4638
1.15
1.17
3.9
3.7
pmol/l
15.0
14.7
1.52
467
4205
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
91
747
1.25
1.15
1.4
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
140
1203
1.20
1.14
5.6
3.8
ng/l
489.8
431.5
0.07
119
935
(3041096) Erythrocytes [Presence] in Urine by Automated
193
1706
1.17
1.14
6.6
3.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
30
2.34
1.12
1.9
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
66
524
1.28
1.11
9.5
3.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
41
1.96
1.09
1.4
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
41
1.96
1.09
1.4
1.3
—
—
—
0
0
(4010399)
56
436
1.31
1.09
1.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
52
1.93
1.06
1.2
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
33
2.13
1.05
1.3
1.1
iu/ml
333.2
154.5
—
7
33
(3007164) IgA [Mass/volume] in Serum or Plasma
141
1222
1.19
1.05
1.7
1.4
g/l
2.4
2.5
0.27
99
763
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
34
2.07
1.03
4.4
3.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
53
1.90
1.01
1.3
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.8
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
54
1.86
0.97
1.4
1.9
nmol/l
15.0
21.6
—
10
49
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
37
1.90
0.94
1.7
2.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
7
37
1.90
0.94
4.7
4.1
mu/l
24.7
18.2
—
7
37
(3003327) Ova and parasites identified in Stool by Light microscopy
28
201
1.41
0.92
1.6
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
104
0.48
0.89
1.2
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
187
1.40
0.86
1.2
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
44
1.83
0.86
1.5
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
44
1.83
0.86
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
112
1.53
0.85
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.5
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.5
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.5
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.5
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
111
963
1.18
0.84
1.3
1.3
u/ml
14.2
10.2
0.19
34
378
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
188
1.40
0.84
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
65
1.70
0.82
5.2
3.8
—
—
—
0
0
(4027681)
6
32
1.88
0.82
1.5
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
32
419
0.75
0.82
1.6
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
95
816
1.19
0.81
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
39
303
1.30
0.81
7.6
3.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
87
742
1.19
0.80
2.7
2.5
ug/g
167.1
119.2
0.51
72
592
(42529406) Shigella sp [Presence] in Stool by Culture
26
190
1.38
0.80
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
234
0.68
0.78
1.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
34
438
0.77
0.78
4.1
2.7
e9/l
3.8
4.1
0.33
29
356
(3051593) INR in Capillary blood by Coagulation assay
0
27
0.00
0.77
0.0
13.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
598
6156
0.88
0.77
5.3
4.4
mmol/l
6.0
6.0
0.03
563
5646
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
312
0.73
0.75
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
167
1.39
0.74
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
79
674
1.19
0.74
1.4
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
55
1.64
0.73
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
22
298
0.73
0.72
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
19
134
1.43
0.72
1.5
1.3
e6/l
3.9
12.0
0.80
14
107
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
19
134
1.43
0.72
1.6
1.4
e6/l
355.1
1445.5
0.57
14
110
(3002523) Influenza virus A Ag [Presence] in Specimen
16
109
1.48
0.71
1.9
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
109
1.48
0.71
1.9
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.2
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.2
2.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
329
1.26
0.69
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
27
1.86
0.68
1.2
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
102
1.48
0.68
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
645
6301
1.13
0.64
5.7
4.4
mmol/l
4.5
4.6
3.33
615
5850
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
29
1.73
0.64
2.2
1.2
mmol/l
5.4
6.6
—
5
29
(3023419) Bacteria identified in Sputum by Culture
13
87
1.50
0.63
2.7
2.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
121
1.41
0.62
1.4
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
71
1.56
0.62
1.4
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
63
1.59
0.62
2.4
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
96
1.47
0.61
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
20
0.00
0.60
0.0
1.3
—
8.4
—
0
20
(3017446) Testosterone [Moles/volume] in Serum or Plasma
70
606
1.17
0.58
2.0
2.3
nmol/l
11.9
13.5
0.92
60
545
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
35
1.72
0.57
4.3
2.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
54
1.49
0.57
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
32
396
0.80
0.57
1.3
1.2
iu/ml
52.9
141.5
1.70
12
153
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
620
6056
1.11
0.57
5.1
3.9
mmol/l
1.4
1.3
2.35
590
5576
(3026470) Cobalt [Mass/volume] in Blood
6
38
1.58
0.54
3.2
2.2
ug/l
1.4
3.4
—
6
33
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
38
1.58
0.54
1.3
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
99
1.42
0.54
2.6
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
62
1.46
0.53
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
39
1.54
0.53
1.3
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
39
1.54
0.53
1.3
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
1.4
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
63
1.43
0.52
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
63
1.43
0.52
1.1
1.5
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
40
1.50
0.51
1.2
1.5
—
23.7
—
0
7
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
65
1.39
0.50
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
377
0.82
0.49
1.1
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
166
0.72
0.48
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
120
1.34
0.46
1.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
57
651
0.87
0.46
1.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
153
0.72
0.46
1.5
1.7
iu/l
621.6
6.2
—
5
48
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
83
0.60
0.46
1.2
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
13
175
0.74
0.45
1.6
1.9
pmol/l
169.5
215.5
1.45
13
166
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
40
340
1.19
0.44
1.8
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
166
1.27
0.43
1.6
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
677
6668
1.10
0.43
27.3
12.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
651
6401
1.09
0.43
6.0
4.8
mmol/l
2.6
2.8
4.39
619
5907
(3019225) pH of Specimen
67
596
1.14
0.42
15.9
3.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.1
—
15.9
—
0
16
(4133840)
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
138
0.72
0.40
1.8
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
60
1.34
0.40
1.1
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
103
0.68
0.39
2.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
103
0.68
0.39
2.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
97
1.35
0.39
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
105
0.66
0.39
2.1
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
66
1.37
0.38
1.6
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.4
1.3
—
—
—
0
0
(4146454)
9
67
1.35
0.38
3.2
2.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
68
1.33
0.37
2.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
113
0.71
0.37
1.1
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
19
152
1.26
0.37
1.4
1.4
mg/l
453.3
468.8
0.09
19
144
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
17
134
1.27
0.37
1.5
1.3
mmol/l
4.0
3.7
0.83
17
126
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
264
2750
0.94
0.34
4.3
4.8
ug/l
4.2
2.4
0.61
235
2470
(40768804) Tissue Pathology biopsy report
253
2425
1.06
0.33
2.2
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
188
0.79
0.33
6.3
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
165
1.22
0.31
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
68
620
1.11
0.31
3.9
4.6
ug/l
24.4
25.7
0.02
53
524
(3000963) Hemoglobin [Mass/volume] in Blood
707
7136
0.92
0.30
41.6
20.4
g/l
131.5
137.3
16.95
702
7026
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
213
2224
0.94
0.30
3.9
4.1
%
23.6
21.1
1.40
97
1013
(3032773) Endomysium IgG Ab [Titer] in Serum
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
707
7135
0.92
0.29
41.5
20.3
e9/l
7.0
6.7
3.21
694
6944
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
56
1.25
0.29
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
417
4068
1.05
0.29
3.2
3.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
707
7133
0.92
0.28
41.4
20.3
e12/l
4.4
4.5
12.37
696
6944
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
577
5680
1.06
0.28
4.5
4.4
mu/l
2.0
2.3
0.58
551
5193
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
634
6258
1.06
0.28
5.7
4.3
mmol/l
1.4
1.4
1.89
605
5775
(3035941) MCH [Entitic mass]
707
7132
0.92
0.28
41.2
20.2
pg
30.3
30.4
0.48
702
7023
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
64
1.25
0.27
1.3
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
64
1.25
0.27
1.1
2.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
707
7131
0.92
0.27
41.3
20.3
fl
91.3
90.9
1.13
702
7024
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
117
1103
1.07
0.26
3.7
3.1
mmol/l
2.5
2.4
0.23
107
967
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
10
77
1.30
0.26
1.3
1.4
—
0.4
—
0
8
(3007461) Platelets [#/volume] in Blood
707
7129
0.93
0.26
41.6
20.3
e9/l
249.9
246.2
0.80
698
6952
(3045142) Bone marrow Pathology biopsy report
9
74
1.22
0.25
1.7
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
202
0.84
0.25
1.3
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
41
454
0.90
0.24
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
158
0.82
0.23
1.5
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
243
0.86
0.23
1.6
1.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
39
1.28
0.23
1.2
1.1
—
5.1
—
0
10
(3028300) Cannabinoids [Presence] in Urine
21
242
0.86
0.22
6.8
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
72
770
0.93
0.21
5.5
4.4
%
32.5
31.3
0.44
59
521
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
124
0.80
0.21
1.7
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
124
0.80
0.21
1.7
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
124
0.80
0.21
1.7
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
124
0.80
0.21
1.7
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
64
595
1.08
0.21
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
21
241
0.87
0.21
5.0
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
685
6792
1.06
0.21
16.8
10.3
u/l
24.9
27.6
5.50
672
6571
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
13
0.00
0.21
0.0
5.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
33
297
1.12
0.20
1.1
1.1
—
78.7
—
0
7
(3027944) Amphetamines [Presence] in Urine
21
240
0.87
0.20
4.5
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
21
240
0.87
0.20
4.9
2.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.9
—
0
9
(40758292) HTLV I+II Ab panel - Serum
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
30
270
1.12
0.19
1.7
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
164
0.85
0.18
7.0
4.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
10
121
0.82
0.18
4.3
2.8
nmol/l
0.9
0.9
—
10
100
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
21
237
0.88
0.18
1.7
1.8
nmol/l
33.1
40.4
1.20
21
229
(3011288) Drugs identified in Urine by Screen method
18
157
1.15
0.17
5.3
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
243
1.12
0.17
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
63
1.11
0.17
1.3
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
130
1351
0.95
0.17
1.2
1.3
u/ml
1.2
1.6
0.38
39
393
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
69
0.72
0.17
1.6
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
68
1.18
0.16
1.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
174
1794
0.96
0.16
1.6
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
604
5985
1.04
0.16
24.9
12.7
ml/min/173m2
71.4
82.6
16.52
529
4968
(4034850)
18
203
0.88
0.15
21.9
11.1
—
—
—
0
0
(4094501)
20
179
1.12
0.14
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
151
1.13
0.13
1.1
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
85
1.18
0.12
1.2
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
24
261
0.92
0.11
2.7
1.9
mg/l
8.2
2.9
0.50
16
185
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
86
1.16
0.11
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
86
1.16
0.11
1.2
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
1.0
1.7
g/l
1.0
1.0
—
5
46
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
68
706
0.96
0.09
1.4
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
87
1.15
0.09
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
87
1.15
0.09
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
87
1.15
0.09
1.2
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
106
1090
0.97
0.09
1.6
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
226
0.93
0.08
5.0
2.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
236
0.93
0.08
3.1
1.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
88
1.14
0.08
4.9
2.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
88
1.14
0.08
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
67
1.05
0.08
1.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
1.4
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
82
0.85
0.07
3.3
3.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
69
711
0.97
0.07
2.4
2.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
85
0.82
0.07
3.0
3.4
u/ml
55.1
26.9
—
7
85
(3000492) Spirometry study
63
644
0.98
0.04
1.5
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
101
1.09
0.04
1.5
3.0
u/ml
8.3
43.3
0.42
11
94
(3002256) Pathology report gross observation
79
804
0.98
0.03
1.3
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
141
1.07
0.03
3.0
3.8
mg/l
24.6
27.6
—
5
94
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
122
1.07
0.02
1.3
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
107
0.93
0.02
1.3
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
433
4318
1.01
0.02
3.8
3.3
u/l
56.5
50.6
0.54
416
4055
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
88
871
1.01
0.01
1.8
1.9
%
1.6
1.5
0.52
72
773
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
64
648
0.99
0.01
2.4
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
106
0.94
0.01
9.1
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
144
1.04
0.00
1.5
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
41
404
1.02
0.00
1.3
1.3
—
48.5
—
0
27
(3009542) Hematocrit [Volume Fraction] of Blood
589
5884
1.00
0.00
28.6
14.8
%
39.1
40.3
2.60
417
4333
(40768443) Skin Pathology biopsy report
25
255
0.98
0.00
1.3
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
113
0.97
0.00
1.1
1.1
u/ml
0.1
2.6
—
5
48
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
26
256
1.02
0.00
3.1
2.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
12
118
1.02
0.00
1.3
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
148
1.01
0.00
1.1
1.2
—
—
—
0
0
(3013512) EKG study
182
1816
1.00
0.00
4.8
3.8
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(4281824)
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
191.3
—
0
6
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
150
1.00
0.00
1.5
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
40.3
—
0
7
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
2.5
—
0.3
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
89
1.01
0.00
1.0
1.1
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.3
—
0
5
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
10.0
—
0
6
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
8
82
0.98
0.00
1.7
1.3
mmol/l
8.3
7.3
—
8
56
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
6.8
—
0
6
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_ACUTENEPHRITIC and mortality.

Females

Parameter HR [95% CI] p-value
N14_ACUTENEPHRITIC 2.352 [1.85, 2.99] < 0.001
Birth year 0.997 [0.99, 1.01] 0.542

During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 1006 females with N14_ACUTENEPHRITIC died.

Males

Parameter HR [95% CI] p-value
N14_ACUTENEPHRITIC 2.225 [1.81, 2.73] < 0.001
Birth year 0.991 [0.98, 1.0] 0.05

During the follow-up period (1.1.1998 — 31.12.2019), 333 out of 1234 males with N14_ACUTENEPHRITIC died.

Mortality risk

Mortality risk for people of age

years, who have N14_ACUTENEPHRITIC.

N-year risk Females Males
1 0.177% 0.529%
5 1.543% 3.105%
10 3.692% 7.535%
15 6.689% 13.671%
20 11.881% 22.28%

Relationships between endpoints

↥

Index endpoint: N14_ACUTENEPHRITIC – Acute nephritic syndrome

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data